Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome

EMBO Mol Med. 2016 Feb 1;8(2):139-54. doi: 10.15252/emmm.201505644.

Abstract

Barth syndrome (BTHS) is a cardiomyopathy caused by the loss of tafazzin, a mitochondrial acyltransferase involved in the maturation of the glycerophospholipid cardiolipin. It has remained enigmatic as to why a systemic loss of cardiolipin leads to cardiomyopathy. Using a genetic ablation of tafazzin function in the BTHS mouse model, we identified severe structural changes in respiratory chain supercomplexes at a pre-onset stage of the disease. This reorganization of supercomplexes was specific to cardiac tissue and could be recapitulated in cardiomyocytes derived from BTHS patients. Moreover, our analyses demonstrate a cardiac-specific loss of succinate dehydrogenase (SDH), an enzyme linking the respiratory chain with the tricarboxylic acid cycle. As a similar defect of SDH is apparent in patient cell-derived cardiomyocytes, we conclude that these defects represent a molecular basis for the cardiac pathology in Barth syndrome.

Keywords: Barth syndrome; cardiolipin; mitochondria; respiratory chain; succinate dehydrogenase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Barth Syndrome / pathology*
  • Cells, Cultured
  • Disease Models, Animal
  • Humans
  • Mice
  • Succinate Dehydrogenase / deficiency*

Substances

  • Succinate Dehydrogenase